SCHEMBL21905243

SCHEMBL21905243

Cc1nc2c(C(=O)O)cc(-c3ccc(-c4cccc(CN5CCCC5)c4)cc3)cc2[nH]1

nearest known ligand 0.83

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 20/20 0.83

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21905255 0.99 DHODH (0.81) DHODH
SCHEMBL21905267 0.92 DHODH (0.79) DHODH
SCHEMBL20482588 0.92 DHODH (0.79) DHODH
SCHEMBL21905315 0.92 DHODH (0.79) DHODH
SCHEMBL21905278 0.91 DHODH (0.81) DHODH
SCHEMBL30572520 0.91 DHODH (0.77) DHODH
SCHEMBL21905253 0.91 DHODH (0.77) DHODH
SCHEMBL30572627 0.91 DHODH (1.00) DHODH
SCHEMBL21905362 0.91 DHODH (1.00) DHODH
SCHEMBL21905274 0.90 DHODH (0.82) DHODH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3585772-B1 1, 4, 6-TRISUBSTITUTED-2-ALKYL-1H-BENZO[D]IMIDAZOLE DERIVATIVES AS DIHYDROOROTATE OXYGENASE INHIBITORS MERCK PATENT GMBH (DE) 2023-10-11 EP claimed
US-11028054-B2 1, 4, 6-trisubstituted-2-alkyl-1H-benzo[d]imidazole derivatives as dihydroorotate oxygenase inhibitors MERCK PATENT GMBH (DE) 2021-06-08 US claimed
US-20200140395-A1 1, 4, 6-TRISUBSTITUTED-2-ALKYL-1H-BENZO[D]IMIDAZOLE DERIVATIVES AS DIHYDROOROTATE OXYGENASE INHIBITORS MERCK PATENT GMBH (DE) 2020-05-07 US claimed
EP-3585772-B1 1, 4, 6-TRISUBSTITUTED-2-ALKYL-1H-BENZO[D]IMIDAZOLE DERIVATIVES AS DIHYDROOROTATE OXYGENASE INHIBITORS MERCK PATENT GMBH (DE) 2023-10-11 EP disclosed
US-11028054-B2 1, 4, 6-trisubstituted-2-alkyl-1H-benzo[d]imidazole derivatives as dihydroorotate oxygenase inhibitors MERCK PATENT GMBH (DE) 2021-06-08 US disclosed
US-20200140395-A1 1, 4, 6-TRISUBSTITUTED-2-ALKYL-1H-BENZO[D]IMIDAZOLE DERIVATIVES AS DIHYDROOROTATE OXYGENASE INHIBITORS MERCK PATENT GMBH (DE) 2020-05-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200140395-A1 1, 4, 6-TRISUBSTITUTED-2-ALKYL-1H-BENZO[D]IMIDAZOLE DERIVATIVES AS DIHYDROOROTATE OXYGENASE INHIBITORS DHODH, HAAO, OGDH DHODH 1/4885
US-11028054-B2 1, 4, 6-trisubstituted-2-alkyl-1H-benzo[d]imidazole derivatives as dihydroorotate oxygenase inhibitors DHODH, HAAO, OGDH DHODH 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.